Acadia Healthcare Company, Inc. Financial Ratios — ACHC

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	137.33	71.07	2.82	61.45	-51.45	35.35	- -	- -	- -	-15.1	98.15	- -
Return on Assets (%)	-16.9	2.92	3.86	4.84	3.47	0.12	3.21	-2.79	1.67	-10.05	3.38	5.6	-0.42	4.52	-19.2
Return on Capital (%)	- -	11.42	12.13	12.64	10.19	1.04	9.65	-0.52	6.65	-16.81	10.76	18.97	- -	15.56	- -
Return on Invested Capital (%)	- -	6.96	7.76	7.56	7.43	1.21	6.59	4.63	3.8	5.2	6.65	8.07	- -	8.35	- -
Gross Margin (%)	94.76	95.22	94.73	95.18	95.5	95.82	95.97	95.72	95.74	95.83	96.08	96.16	96.38	96.43	96.44
EBITDA Margin (%)	7.64	19.31	19.64	20.45	21.42	20.64	20.48	20.26	20.02	22.05	22.52	22.43	22.04	21.3	17.42
Operating Margin (%)	5.67	17.35	17.24	17.2	17.88	15.84	15.44	16.04	15.64	17.49	17.91	17.92	17.52	16.56	11.71
Incremental Operating Margin (%)	2.24	30.6	17.09	17.09	18.74	12.23	-28.58	14.21	8.25	63.17	21.77	17.98	14.24	4.11	-84.58
Pretax Margin (%)	-17.77	8.06	9.71	12.56	9.18	1.17	8.35	3.54	3.9	8.79	11.91	14.33	-0.87	10.84	-32.18
Profit Margin (%)	-16.12	5.01	5.97	8.27	6.27	0.22	7.05	-9.23	5.42	-32.16	8.24	10.46	-0.74	8.1	-33.29
Net Income to Common Margin (%)	-16.12	5.01	5.97	8.27	6.27	0.22	7.05	-9.23	5.42	-32.16	8.24	10.46	-0.74	8.1	-33.29
Effective Tax Rate (%)	- -	37.54	37.51	34.02	32.4	87.33	15.71	14.7	32	22.09	24.5	25.15	- -	22.64	- -
Dvd Payout Ratio (%)	-225.39	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	137.33	71.07	2.82	61.45	-51.45	35.35	- -	- -	- -	-15.1	98.15	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	277	473	617	1,080	2,241	3,288	3,240	3,193	3,257	3,258	1,638	1,530	1,500	2,085	2,644
ST Debt	7	8	15	27	45	35	35	34	66	205	43	49	56	103	51
LT Debt	271	466	602	1,053	2,195	3,253	3,205	3,159	3,191	3,053	1,595	1,481	1,443	1,982	2,593
Total Debt/EBITDA	16.76	6.01	4.41	5.26	5.83	5.67	5.58	8.28	8.1	7.07	3.14	2.61	2.32	3.1	4.58
Net Debt/EBITDA	13.07	5.39	4.37	4.8	5.8	5.57	5.46	8.14	7.59	5.95	2.62	2.2	1.97	2.8	4.1
Total Debt/EBIT	22.61	6.69	5.02	6.25	6.98	7.39	7.4	10.45	10.37	8.91	3.95	3.27	2.92	3.99	6.82
Net Debt/EBIT	17.63	6	4.98	5.7	6.95	7.26	7.25	10.29	9.71	7.5	3.29	2.75	2.48	3.6	6.1
EBITDA to Interest Expense	1.8	2.64	3.76	4.26	3.6	3.2	3.3	2.09	2.15	2.91	6.77	8.39	7.86	5.77	4.16
EBITDA-CapEx/Interest Expense	0.85	0.86	3.54	3.78	3.35	2.98	3.07	1.99	2.15	2.91	6.77	8.39	7.86	5.77	4.16
EBIT to Interest Expense	1.34	2.38	3.3	3.58	3.01	2.45	2.49	1.66	1.68	2.31	5.38	6.7	6.25	4.49	2.79
Interest Expense	9	30	37	48	107	181	176	185	187	158	77	70	82	116	139
Common Equity/Total Assets	-10.72	-2.41	1.54	4.62	5.02	3.67	6.68	4.11	5.27	-4.76	-2.49	3.09	2.48	6.52	-13.84
Long-Term Debt/Equity (%)	280.92	107.65	125.22	119.49	130.44	150.07	124.57	135.4	127.37	160.73	61.77	51.05	49.98	62.11	121.16
Long-Term Debt/Capital (%)	116.08	103.56	94.64	89.08	89.12	92.24	86.82	91.65	88.17	103.56	100.67	83.57	83.04	76.5	125.24
Long-Term Debt/Total Assets (%)	65.55	47.35	49.15	47.7	51.3	53.99	49.89	51.18	46.39	46.97	33.46	29.69	26.93	33.27	46.92
Total Debt/Equity (%)	287.93	109.43	128.38	122.55	133.14	151.67	125.93	136.87	129.99	171.5	63.43	52.73	51.94	65.35	123.53
Total Debt/Capital (%)	118.98	105.27	97.03	91.37	90.96	93.23	87.76	92.64	89.98	110.5	103.37	86.31	86.29	80.49	127.69
Total Debt/Total Assets (%)	67.18	48.13	50.39	48.92	52.36	54.57	50.43	51.74	47.34	50.12	34.36	30.67	27.99	35.01	47.84
Net Debt to Equity	224.5	98	127.43	111.88	132.47	149.04	123.31	134.7	121.72	144.45	52.79	44.4	44.04	58.94	110.57
Net Debt/Capital (%)	125.72	105.92	97.01	90.62	90.92	93.12	87.53	92.53	86.64	106.79	93.96	76.92	77.63	74.79	122.15
EBITDA	17	79	140	205	384	580	581	386	402	461	521	585	645	672	577
EBITDA-CapEx	8	26	132	182	358	539	540	367	402	461	521	585	645	672	577
Operating Income (Loss)	12	71	123	173	321	445	438	306	314	366	414	468	513	522	388

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.5	0.69	0.04	0.57	0.04	0.17	0.18	0.12	0.21	0.29	0.33	0.25	0.11	0.13	0.25
Current Ratio	2.77	1.96	1.27	1.65	1.02	1.25	1.25	1.08	1.17	1.93	1.22	1.3	0.67	1	1.55
Quick Ratio	2.37	1.58	1	1.4	0.89	1.12	1.13	0.97	0.91	0.52	1.08	1.16	0.6	0.86	1.29
CFO/Avg Current Liab	-1.02	0.6	0.7	0.82	1.05	1.14	1.11	1.04	0.76	0.74	0.44	0.96	0.73	0.18	0.24
Common Equity/Total Assets	-10.72	-2.41	1.54	4.62	5.02	3.67	6.68	4.11	5.27	-4.76	-2.49	3.09	2.48	6.52	-13.84
Long-Term Debt/Equity (%)	280.92	107.65	125.22	119.49	130.44	150.07	124.57	135.4	127.37	160.73	61.77	51.05	49.98	62.11	121.16
Long-Term Debt/Capital (%)	116.08	103.56	94.64	89.08	89.12	92.24	86.82	91.65	88.17	103.56	100.67	83.57	83.04	76.5	125.24
Long-Term Debt/Total Assets (%)	65.55	47.35	49.15	47.7	51.3	53.99	49.89	51.18	46.39	46.97	33.46	29.69	26.93	33.27	46.92
Total Debt/Equity (%)	287.93	109.43	128.38	122.55	133.14	151.67	125.93	136.87	129.99	171.5	63.43	52.73	51.94	65.35	123.53
Total Debt/Capital (%)	118.98	105.27	97.03	91.37	90.96	93.23	87.76	92.64	89.98	110.5	103.37	86.31	86.29	80.49	127.69
Total Debt/Total Assets (%)	67.18	48.13	50.39	48.92	52.36	54.57	50.43	51.74	47.34	50.12	34.36	30.67	27.99	35.01	47.84
CFO/Total Liabilities	-6.53	6.15	8.81	8.69	9.26	9.37	10.37	10.79	7.61	14.32	17.14	18.24	18.71	4.69	3.89
CFO/CapEx	-2.37	0.64	8.1	4.97	9.03	8.87	9.73	22.53	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	1.64	2.66	4.09	2.86	2.49	1.88	1.83	1.25	1.17	1.57	2.93	3.8	3.17	2.28	1.16

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	12.33	8.23	8.93	9.38	10.71	11.71	10.13	6.19	6.62	7.43	8.34	8.65	8.56	8.68	8.22
Days Sales Outstanding	29.61	44.34	40.87	38.92	34.07	31.16	36.05	58.93	55.15	49.11	43.75	42.21	42.62	42.05	44.4
Inventory Turnover	- -	- -	- -	29.81	20.34	25.21	24.3	16.55	18.74	19.55	18.82	20.3	20.41	20.58	20.82
Days Inventory Outstanding	- -	- -	- -	12.25	17.94	14.48	15.02	22.05	19.48	18.67	19.39	17.98	17.88	17.74	17.53
Accounts Payable Turnover	2.63	1.41	1.36	1.22	1.17	1.37	1.26	0.74	0.81	0.99	0.97	0.99	0.81	0.58	0.62
Accounts Payable Turnover Days	138.97	259.51	267.69	299.23	311.31	266.46	290.38	491.34	448.94	369.23	375.3	369.17	448.25	627.62	592.12
Cash Conversion Cycle	-109.36	-215.17	-226.83	-248.07	-259.3	-220.82	-239.31	-410.36	-374.3	-301.44	-312.16	-308.98	-387.75	-567.82	-530.19
Inventory to Cash Days	29.61	44.34	40.87	26.68	16.13	16.69	21.03	36.88	35.67	30.44	24.36	24.23	24.73	24.32	26.87
Inventories	- -	- -	- -	3	5	5	5	5	4	5	5	5	5	6	6
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	3	5	5	5	5	4	5	5	5	5	6	6

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	187	898	2,367	3,370	4,253	2,837	2,837	2,244	2,910	4,417	5,388	7,382	7,072	3,633	1,287
- Cash & Cash Equivalents	61	49	5	94	11	57	67	51	100	379	134	98	100	76	133
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	8	18	22	- -	- -	- -	65	88	106	117	192
+ Total Debt	277	473	617	1,080	2,241	3,288	3,240	3,193	3,257	3,258	1,638	1,530	1,500	2,085	2,644
Enterprise Value	403	1,322	2,979	4,356	6,490	6,085	6,032	5,387	6,068	7,295	6,958	8,903	8,578	5,759	3,990
Total Capital	233	450	636	1,182	2,464	3,527	3,692	3,447	3,619	2,948	1,585	1,772	1,738	2,591	2,071
Total Debt/Capital (%)	118.98	105.27	97.03	91.37	90.96	93.23	87.76	92.64	89.98	110.5	103.37	86.31	86.29	80.49	127.69
Total Debt / EV	0.69	0.36	0.21	0.25	0.35	0.54	0.54	0.59	0.54	0.45	0.24	0.17	0.17	0.36	0.66
EV/Sales	1.86	3.25	4.18	4.34	3.62	2.16	2.13	2.83	3.02	3.49	3.01	3.41	2.93	1.83	1.2
EV/EBITDA	24.37	16.8	21.27	21.2	16.89	10.49	10.38	13.96	15.09	15.83	13.35	15.21	13.29	8.57	6.91
EV/EBIT	32.87	18.7	24.22	25.21	20.23	13.67	13.78	17.63	19.32	19.95	16.79	19.04	16.72	11.03	10.28
EV/Cash Flow to Firm	- -	25.19	33.54	29.61	20.76	15.83	11.01	9.43	13.18	9.33	16.08	20.57	16.72	26.21	14.55
EV/Free Cash Flow to Firm	- -	12.52	30.74	25.58	19.14	14.31	10.24	9.13	13.18	9.33	16.08	20.57	16.72	26.21	14.55
Diluted Market Cap	187	904	2,379	3,387	4,272	2,846	2,841	2,244	2,917	4,453	5,511	7,537	7,072	3,650	1,287
Diluted Enterprise Value	403	1,327	2,991	4,372	6,509	6,094	6,036	5,387	6,074	7,332	7,081	9,057	8,578	5,776	3,990
EV per Share	21.5	34.37	59.58	79.11	95.32	71.01	69.38	61.72	69.25	83.02	78.39	99.27	94.31	62.86	43.98
TTM Sales	216	407	713	1,005	1,794	2,811	2,836	1,905	2,008	2,090	2,314	2,610	2,929	3,154	3,313
TTM EBITDA	17	79	140	205	384	580	581	386	402	461	521	585	645	672	577
TTM Operating Income	12	71	123	173	321	445	438	306	314	366	414	468	513	522	388
TTM Cash Flow to Firm	-13	52	89	147	313	384	548	571	460	782	433	433	513	220	274
TTM Free Cash Flow to Firm	-4	106	97	170	339	425	589	590	460	782	433	433	513	220	274

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-15.64	10.38	32.3	24.46	16	7.07	6.45	5.19	8.76	6.76	14.72	19.8	15.3	28.14	9.76
EV/EBIT	32.87	18.7	24.22	25.21	20.23	13.67	13.78	17.63	19.32	19.95	16.79	19.04	16.72	11.03	10.28
Enterprise Value	403	1,322	2,979	4,356	6,490	6,085	6,032	5,387	6,068	7,295	6,958	8,903	8,578	5,759	3,990
Low Price	5.43	9.38	22.64	38.76	54.41	32.54	26.92	24.27	25.13	11.09	48.62	50.07	66.49	36.5	12.63
EV/Sales	1.86	3.25	4.18	4.34	3.62	2.16	2.13	2.83	3.02	3.49	3.01	3.41	2.93	1.83	1.2
EV/EBITDA	24.37	16.8	21.27	21.2	16.89	10.49	10.38	13.96	15.09	15.83	13.35	15.21	13.29	8.57	6.91
Price/Earnings	- -	44.03	55.58	40.59	37.78	461.78	14.2	- -	26.72	- -	28.26	27.03	- -	14.21	- -
Price/Earnings Average	-5.32	33.61	41.15	33.24	42.1	719.86	18.3	-18.81	24.64	-4.01	27.92	23.85	-313.71	24.03	-2.1
Price/Earnings High	-8.28	46.83	57.71	44.35	51.79	919.23	23.64	-22.52	28.47	-6.67	31.97	29.5	-362.55	31.46	-3.87
Price/Earnings Low	-2.92	17.69	26.59	25.7	32.91	453.97	11.71	-12.05	20.21	-1.45	22.64	16.44	-279.1	13.08	-1.04
Price/Book Value	-4.23	-37.94	125.2	33.03	19.81	12.84	6.61	8.85	8.03	-14.27	-45.33	47.85	53.32	9.36	-1.68
Price/Book Value Average	-4.2	-28.96	92.68	27.05	22.07	20.01	8.52	13.03	7.4	-8.7	-44.77	42.23	51.25	15.82	-3.03
Price/Book Value High	-6.53	-40.35	129.99	36.09	27.15	25.55	11	15.6	8.55	-14.48	-51.27	52.23	59.23	20.71	-5.58
Price/Book Value Low	-2.3	-15.24	59.89	20.92	17.25	12.62	5.45	8.35	6.07	-3.15	-36.31	29.1	45.59	8.61	-1.5
Price/Tangible Book Value	-1.9	-6.38	-11.75	59.82	-8.42	-4.75	-10.68	-14.76	8.28	-16.1	17.23	12.26	12.02	4.24	1.72
Price/Tangible Book Value Average	-1.88	-4.87	-8.7	48.99	-9.39	-7.41	-13.77	-21.74	7.64	-9.82	17.01	10.82	11.55	7.18	3.1
Price/Tangible Book Value High	-2.93	-6.78	-12.2	65.36	-11.55	-9.46	-17.79	-26.03	8.82	-16.33	19.48	13.38	13.35	9.39	5.71
Price/Tangible Book Value Low	-1.03	-2.56	-5.62	37.88	-7.34	-4.67	-8.81	-13.93	6.26	-3.55	13.8	7.46	10.28	3.91	1.53
Price/Sales	0.86	2.2	3.32	3.35	2.37	1.01	1	1.18	1.45	2.11	2.33	2.83	2.41	1.15	0.39
Price/Sales Average	0.86	1.68	2.46	2.75	2.64	1.57	1.29	1.74	1.34	1.29	2.3	2.5	2.32	1.95	0.7
Price/Sales High	1.33	2.34	3.44	3.67	3.25	2.01	1.67	2.08	1.54	2.14	2.63	3.09	2.68	2.55	1.29
Price/Sales Low	0.47	0.89	1.59	2.12	2.06	0.99	0.83	1.11	1.1	0.47	1.86	1.72	2.06	1.06	0.35
Price/Cash Flow	-9.05	26.5	36.1	29.24	17.69	7.85	7.1	5.42	8.74	6.7	14.39	19.4	15.3	28.01	9.76
Price/Cash Flow Average	-8.99	20.23	26.72	23.94	19.71	12.23	9.15	7.99	8.06	4.09	14.21	17.12	14.7	47.36	17.59
Price/Cash Flow High	-13.98	28.18	37.48	31.94	24.25	15.62	11.82	9.56	9.32	6.8	16.27	21.17	16.99	62	32.38
Price/Cash Flow Low	-4.93	10.65	17.27	18.51	15.41	7.71	5.86	5.12	6.61	1.48	11.53	11.8	13.08	25.79	8.69
Price/Free Cash Flow Average	-15.53	7.92	23.91	20.03	17.83	11.03	8.31	7.65	8.08	4.12	14.54	17.48	14.7	47.59	17.59
Price/Free Cash Flow High	-24.15	11.04	33.53	26.72	21.93	14.08	10.74	9.15	9.34	6.86	16.64	21.62	16.99	62.3	32.38
Price/Free Cash Flow Low	-8.52	4.17	15.45	15.49	13.94	6.95	5.32	4.9	6.63	1.49	11.79	12.05	13.08	25.91	8.69
EV/Sales Average	1.86	2.72	3.31	3.73	3.89	2.73	2.42	3.39	2.91	2.67	2.98	3.08	2.83	2.62	1.52
EV/Sales High	2.33	3.39	4.3	4.65	4.5	3.16	2.79	3.73	3.12	3.52	3.31	3.67	3.2	3.22	2.1
EV/Sales Low	1.47	1.93	2.45	3.11	3.31	2.15	1.95	2.76	2.67	1.84	2.54	2.3	2.58	1.73	1.16
EV/EBITDA Average	24.3	14.1	16.88	18.23	18.15	13.22	11.8	16.71	14.53	12.09	13.22	13.73	12.86	12.31	8.7
EV/EBITDA High	30.53	17.53	21.91	22.72	20.99	15.33	13.63	18.4	15.57	15.97	14.7	16.36	14.5	15.13	12.08
EV/EBITDA Low	19.23	9.97	12.45	15.19	15.46	10.4	9.53	13.63	13.33	8.36	11.29	10.27	11.7	8.14	6.67
EV/EBIT Average	32.77	15.69	19.23	21.68	21.75	17.23	15.65	21.11	18.6	15.24	16.63	17.18	16.18	15.83	12.95
EV/EBIT High	41.17	19.51	24.96	27.02	25.15	19.98	18.09	23.24	19.93	20.13	18.49	20.48	18.25	19.47	17.97
EV/EBIT Low	25.93	11.1	14.18	18.06	18.52	13.56	12.64	17.22	17.06	10.54	14.2	12.85	14.72	10.47	9.92
Last Price	9.97	23.35	47.33	61.21	62.46	33.1	32.63	25.71	33.22	50.26	60.7	82.32	77.76	39.65	14.19
High Price	15.4	24.83	49.14	66.88	85.62	65.89	54.34	45.35	35.4	50.99	68.65	89.85	86.37	87.77	47.08
Enterprise Value Average	402	1,110	2,365	3,746	6,976	7,671	6,853	6,450	5,841	5,573	6,892	8,036	8,303	8,269	5,022
Enterprise Value High	505	1,379	3,070	4,668	8,067	8,895	7,920	7,101	6,259	7,360	7,664	9,578	9,361	10,168	6,973
Enterprise Value Low	318	785	1,745	3,120	5,942	6,037	5,536	5,261	5,359	3,853	5,886	6,011	7,553	5,470	3,848

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	32	50	50	59	71	87	87	87	88	88	89	90	91	92	90
Diluted Weighted Avg Shares	19	39	50	55	68	86	87	87	88	89	91	92	91	92	91
Basic Weighted Avg Shares	19	38	50	55	68	86	87	87	88	88	89	90	91	92	91
Revenue per Share	11.54	10.59	14.27	18.24	26.36	32.8	32.62	21.82	22.92	23.78	26.07	29.11	32.2	34.42	36.52
EBITDA per Share	0.88	2.05	2.8	3.73	5.65	6.77	6.68	4.42	4.59	5.24	5.87	6.53	7.1	7.33	6.36
Operating Income per Share	0.65	1.84	2.46	3.14	4.71	5.19	5.04	3.5	3.59	4.16	4.67	5.22	5.64	5.7	4.28
Basic EPS, GAAP	-1.86	0.53	0.85	1.51	1.65	0.07	2.3	-2.01	1.24	-7.65	2.15	3.05	-0.24	2.79	-12.16
Basic EPS from Cont Ops	-1.77	0.53	0.87	1.51	1.64	0.05	2.3	0.66	0.61	1.63	2.35	3.12	-0.17	2.89	-12.04
Diluted EPS, GAAP	-1.86	0.53	0.85	1.5	1.65	0.07	2.3	-2.01	1.24	-7.59	2.1	2.98	-0.24	2.78	-12.16
Diluted EPS from Cont Ops	-1.77	0.53	0.86	1.5	1.63	0.05	2.29	0.66	0.61	1.62	2.29	3.06	-0.17	2.87	-12.04
Dividend per Share	3.99	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.1	0.88	1.31	2.09	3.53	4.22	4.6	4.74	3.8	7.5	4.22	4.24	5.08	1.42	1.45
Free Cash Flow per Basic Share	-1.57	-0.5	1.15	1.67	3.14	3.74	4.12	4.53	3.8	7.5	4.22	4.24	5.08	1.42	1.45
Cash & Equivalents per Share	3.26	1.28	0.09	1.71	0.16	0.67	0.77	0.58	1.14	4.31	1.51	1.09	1.1	0.83	1.47
Book Value per Share	-2.36	-0.62	0.38	1.85	3.15	2.58	4.94	2.91	4.14	-3.52	-1.34	1.72	1.46	4.24	-8.43
Tangible Book Value per Share	-5.26	-3.66	-4.03	1.02	-7.41	-6.96	-3.06	-1.74	4.01	-3.12	3.52	6.71	6.47	9.34	8.24

Acadia Healthcare Company, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)